Natera

Bewertungs-Analyse

★ Smart Money Investoren

Diese Aktie wird von einem oder mehreren unserer 15 getrackten Smart Money Manager gehalten. Klicke auf einen Namen um das vollständige Portfolio zu sehen.

Über das Unternehmen

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and

Trading-Daten

Ähnliche Aktien aus dem Sektor

Wo kann ich Natera kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.